Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period [Phase 3]

View source ↗

Summary

Phase 3 pediatric study assessing efficacy and safety of pitolisant in narcolepsy with and without cataplexy completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pitolisant (pitolisant)

Snippet

Sponsor: Bioprojet | Conditions: Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19